Details for New Drug Application (NDA): 203417
✉ Email this page to a colleague
The generic ingredient in FELODIPINE is felodipine. There are seventeen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the felodipine profile page.
Summary for 203417
Tradename: | FELODIPINE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | felodipine |
Patents: | 0 |
Pharmacology for NDA: 203417
Mechanism of Action | Calcium Channel Antagonists |
Medical Subject Heading (MeSH) Categories for 203417
Suppliers and Packaging for NDA: 203417
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 203417 | ANDA | A-S Medication Solutions | 50090-5870 | 50090-5870-0 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-5870-0) |
FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 203417 | ANDA | Rising Pharma Holdings, Inc. | 57237-108 | 57237-108-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (57237-108-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 2.5MG | ||||
Approval Date: | Jan 17, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MG | ||||
Approval Date: | Jan 17, 2013 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
Approval Date: | Jan 17, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription